This week, Mark and Margaret speak with Dr. Eric Green, Director of the National Human Genome Research Institute, one of the 27 Institutes at NIH. They have launched a new program called Big Data to Knowledge, or BD2K, which seeks to create better platforms for storing and sharing the large volumes of big data that have emerged in the world of scientific research since the mapping of the human genome. Dr. Green also talks about the threats to future research from young scientists struggling to achieve in a climate of reduced grant funding nationwide.
Converting Big Data into Knowledge: Updates from the National Human Genome Research Institute

Transcript
Converting Big Data into Knowledge: Updates from the National Human Genome Research Institute
closeReady to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
This week, Mark and Margaret speak with Dr. Eric Green, Director of the National Human Genome Research Institute, one of the 27 Institutes at NIH. They have launched a new program called Big Data to Knowledge, or BD2K, which seeks to create better platforms for storing and sharing the large volumes of big data that have emerged in the world of scientific research since the mapping of the human genome. Dr. Green also talks about the threats to future research from young scientists struggling to achieve in a climate of reduced grant funding nationwide.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
First-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?